search

Active clinical trials for "Endometrial Neoplasms"

Results 561-570 of 990

Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer

Recurrent Endometrial Carcinoma

This phase II trial is studying how well bevacizumab works in treating patients with recurrent or persistent endometrial cancer. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor.

Completed56 enrollment criteria

Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers...

Ovarian CancerEndometrial Cancer

This is a Phase II clinical trial evaluating the benefit from therapy with vintafolide in participants with advanced ovarian and endometrial cancers.

Completed30 enrollment criteria

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

Cervical CancerEndometrial Cancer3 more

This research study is evaluating a drug called avastin in combination with standard radiation as a possible treatment for treatment for recurrent pelvic-confined gynecological cancer (i.e. endometrial, cervical, vulvar, ovarian or vaginal cancers).

Completed30 enrollment criteria

Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Recurrent Endometrial Carcinoma

This phase II trial is studying how well lapatinib works in treating patients with recurrent or persistent endometrial cancer. Lapatinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth

Completed49 enrollment criteria

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Endometrial Cancer

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well docetaxel works in treating patients with recurrent or persistent endometrial carcinoma (cancer).

Completed56 enrollment criteria

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Endometrial CancerSarcoma

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perifosine in treating patients who have metastatic or locally advanced soft tissue sarcoma.

Completed77 enrollment criteria

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Endometrial AdenoacanthomaEndometrial Adenocarcinoma4 more

Phase II trial to study the effectiveness of thalidomide in treating patients who have recurrent or persistent endometrial cancer. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor

Completed44 enrollment criteria

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From...

Endometrial CancerKidney Cancer4 more

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether surgery plus combination chemotherapy is more effective than surgery alone in treating patients with lung metastases from soft tissue sarcoma. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery plus combination chemotherapy with that of surgery alone in treating patients who have soft tissue sarcoma that has spread to the lung.

Completed3 enrollment criteria

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of...

Endometrial CancerSarcoma

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether receiving radiation therapy or no further therapy after surgery is more effective for cancer of the uterus. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with that of no further therapy in treating patients who have stage I or stage II cancer of the uterus that has been surgically removed.

Completed3 enrollment criteria

Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or...

Endometrial CancerFallopian Tube Cancer2 more

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining doxorubicin and paclitaxel in treating patients who have recurrent or refractory endometrial cancer, fallopian tube cancer, or sarcoma of the female reproductive tract.

Completed3 enrollment criteria
1...565758...99

Need Help? Contact our team!


We'll reach out to this number within 24 hrs